[go: up one dir, main page]

GB0321127D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0321127D0
GB0321127D0 GB0321127A GB0321127A GB0321127D0 GB 0321127 D0 GB0321127 D0 GB 0321127D0 GB 0321127 A GB0321127 A GB 0321127A GB 0321127 A GB0321127 A GB 0321127A GB 0321127 D0 GB0321127 D0 GB 0321127D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0321127A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
AstraZeneca UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca UK Ltd filed Critical AstraZeneca UK Ltd
Priority to GB0321127A priority Critical patent/GB0321127D0/en
Publication of GB0321127D0 publication Critical patent/GB0321127D0/en
Priority to UY28501A priority patent/UY28501A1/en
Priority to AT04768376T priority patent/ATE428701T1/en
Priority to JP2006525882A priority patent/JP2007505090A/en
Priority to ES04768376T priority patent/ES2324042T3/en
Priority to CN2004800308267A priority patent/CN1878760B/en
Priority to KR1020067004952A priority patent/KR20070019943A/en
Priority to PT04768376T priority patent/PT1663989E/en
Priority to NZ545785A priority patent/NZ545785A/en
Priority to CA2537962A priority patent/CA2537962C/en
Priority to BRPI0414236-5A priority patent/BRPI0414236A/en
Priority to UAA200602622A priority patent/UA85062C2/en
Priority to EP04768376A priority patent/EP1663989B1/en
Priority to US10/571,254 priority patent/US20060293355A1/en
Priority to RU2006111354/04A priority patent/RU2363697C2/en
Priority to DK04768376T priority patent/DK1663989T3/en
Priority to AU2004270467A priority patent/AU2004270467B8/en
Priority to SI200431145T priority patent/SI1663989T1/en
Priority to PL04768376T priority patent/PL1663989T3/en
Priority to DE602004020640T priority patent/DE602004020640D1/en
Priority to MXPA06002761A priority patent/MXPA06002761A/en
Priority to PCT/GB2004/003829 priority patent/WO2005023779A1/en
Priority to MYPI20043667A priority patent/MY142615A/en
Priority to ARP040103249A priority patent/AR045628A1/en
Priority to TW093127580A priority patent/TWI370817B/en
Priority to SA04250297A priority patent/SA04250297B1/en
Priority to IL174073A priority patent/IL174073A/en
Priority to ZA200602009A priority patent/ZA200602009B/en
Priority to NO20061181A priority patent/NO336358B1/en
Priority to CO06026185A priority patent/CO5670355A2/en
Priority to IS8385A priority patent/IS2689B/en
Priority to HK06110818A priority patent/HK1090361A1/en
Priority to HR20090335T priority patent/HRP20090335T1/en
Priority to CY20091100661T priority patent/CY1109173T1/en
Priority to US12/615,935 priority patent/US20100222373A1/en
Priority to US13/038,245 priority patent/US8436167B2/en
Priority to US13/858,553 priority patent/US20130225622A1/en
Ceased legal-status Critical Current

Links

GB0321127A 2003-09-10 2003-09-10 Chemical compounds Ceased GB0321127D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GB0321127A GB0321127D0 (en) 2003-09-10 2003-09-10 Chemical compounds
UY28501A UY28501A1 (en) 2003-09-10 2004-09-07 CHEMICAL COMPOUNDS
MXPA06002761A MXPA06002761A (en) 2003-09-10 2004-09-08 Crystalline form of bis [(e)-7 -[4-(4-fluorophenyl) -6-isopropyl -2-[methyl(methylsulfonyl) amino]pyrimidin -5-yl](3r, 5s)-3, 5-dihydroxyhept -6 -enoicacid] calcium salt.
DE602004020640T DE602004020640D1 (en) 2003-09-10 2004-09-08 CRYSTALLINE FORM OF BISEN (E) -7-A4- (4-FLUORPHENYL) -6-ISOPROPYL-2-AMETHYL (METHYLSULFONYL) AMINO-PYRIMIDIN-5-YLÜ (3R, 5S) -3,5-DIHYDROXY-HEPT-6-ACIDIC ACID CALCIUM SALT
JP2006525882A JP2007505090A (en) 2003-09-10 2004-09-08 Bis [(E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S) -3,5-dihydroxy- 6-Heptenoic acid] calcium salt crystal form
ES04768376T ES2324042T3 (en) 2003-09-10 2004-09-08 CRYSTAL FORM OF THE CALCIUM SALT OF BIS (ACID (E) -7- (4- (4-FLUOROPHENIL) -6-ISOPROPIL-2- (METHYL (METILSULFONIL) AMINO) PIRIMIDIN-5-IL) (3R, 5S) -3,5-DIHYDROXIHEPT-6-ENOICO).
CN2004800308267A CN1878760B (en) 2003-09-10 2004-09-08 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt
KR1020067004952A KR20070019943A (en) 2003-09-10 2004-09-08 Bis [(E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S) -3, Crystalline Form of 5-Dihydroxyhept-6-enoic Acid] Calcium Salt
PT04768376T PT1663989E (en) 2003-09-10 2004-09-08 Crystalline form of bis (e)-7- 4-(4-fluorophenyl)-6-is opropyl-2- methyl(methylsulfonyl)amino pyrimidin-5-yl&r sqb;(3r,5s)-3,5-dihydroxyhept-6 -enoicacid calcium salt
NZ545785A NZ545785A (en) 2003-09-10 2004-09-08 Crystalline form of bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoicacid] calcium salt
CA2537962A CA2537962C (en) 2003-09-10 2004-09-08 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6 -enoicacid] calcium salt
BRPI0414236-5A BRPI0414236A (en) 2003-09-10 2004-09-08 crystalline hydrated form of the compound, pharmaceutical composition, processes for forming a compound, for the manufacture of a crystalline form, and a pharmaceutical composition, use of a crystalline form, and method of treating a disease condition
UAA200602622A UA85062C2 (en) 2003-09-10 2004-09-08 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl) -6-isopropyl -2-[methyl(methylsulfonyl) amino]pyrimidin-5-yl](3r, 5s)-3,5-dihydroxyhept-6 -enoic acid] calcium salt
EP04768376A EP1663989B1 (en) 2003-09-10 2004-09-08 CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT
US10/571,254 US20060293355A1 (en) 2003-09-10 2004-09-08 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt
RU2006111354/04A RU2363697C2 (en) 2003-09-10 2004-09-08 Crystalline form of calcium salt of bis-[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulphonyl)amino]-pyrimidin-5-yl](3r, 5s)-3, 5-dihydroxyhept-6-enoic acid
DK04768376T DK1663989T3 (en) 2003-09-10 2004-09-08 Crystalline form of bis (E) -7- [4 (4-fluorophenyl) -6-isopropyl-2-methyl (methylsulfonyl) aminopyrimidin-5-yl (3R, 5S)) - 3-5-dihydroxyhept-6-enoic acid salt
AU2004270467A AU2004270467B8 (en) 2003-09-10 2004-09-08 Crystalline form of bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6 -enoicacid] calcium salt
SI200431145T SI1663989T1 (en) 2003-09-10 2004-09-08 CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT
AT04768376T ATE428701T1 (en) 2003-09-10 2004-09-08 CRYSTALLINE FORM OF BISÄ(E)-7-Ä4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-
PL04768376T PL1663989T3 (en) 2003-09-10 2004-09-08 CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT
PCT/GB2004/003829 WO2005023779A1 (en) 2003-09-10 2004-09-08 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6 -enoicacid] calcium salt
MYPI20043667A MY142615A (en) 2003-09-10 2004-09-09 Crystalline form of bis [ (e)-7-4(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r, 5s)-3,5-dihydroxyhept-6 -enoic acid] calcium salt
ARP040103249A AR045628A1 (en) 2003-09-10 2004-09-10 CRYSTALLINE VARIETIES OF BIS- (ACID (E) -7- {4- (4-FLUOROPHENIL) -6-ISOPROPIL-2- [¨METIL (METILSULFONIL) AMINO] PIRIMIDIN-5-IL} (3R, 5S) -3, 5 DIHYDROXIHEPT-6-ENOICO)
TW093127580A TWI370817B (en) 2003-09-10 2004-09-10 Novel crystalline form of bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[ methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid] calcium salt,and relevant manufacture process, pharmaceutical composition, and use
SA04250297A SA04250297B1 (en) 2003-09-10 2004-09-18 Hydrogenated crystal forms of :pis](E)-7-[4-)(-fluorophenyl)-6isopropyl-2[methyl(methylsu1fonyl) amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept- 6enoic acid] calcium salt
IL174073A IL174073A (en) 2003-09-10 2006-03-02 Crystalline hydrated form of bis [(e) - 7 - [4 - (4 - fluorophenyl) - 6 - isopropyl - 2 - [methyl (methylsulphonyl) amino] pyrimidin - 5 - yl] (3r,5s) - 3,5 - dihydroxyhept - 6 - enoic acid] calcium salt, process for its preparation, pharmaceutical compositions comprising the same and use thereof in the manufacture of a medicament for medical treatment
ZA200602009A ZA200602009B (en) 2003-09-10 2006-03-09 Crystallineformofbis[(E)-7-[4-(4-flourophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R, 5S)-3,5-dihydroxyhept-6-enoicacid] calcium salt
NO20061181A NO336358B1 (en) 2003-09-10 2006-03-14 Crystal forms of the calcium salt of bis [(E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S) -3.5 -dihydroxyhept-6-enoic acid], preparation of such, pharmaceutical preparation containing the same and use thereof for the manufacture of a medicament
CO06026185A CO5670355A2 (en) 2003-09-10 2006-03-15 CRYSTAL FORM OF CALCIUM ACID SALT OF BIS [(E) -7- [4- (4-FLUOROPHENYL) -6-ISOPROPIL-2- [METHYL (METILSULFONIL) AMINO] PIRIMIDIN-5-IL] (3R, 5S) - 3,5-DIHYDROXIHEPT-6-ENOICO
IS8385A IS2689B (en) 2003-09-10 2006-03-30 Crystalline form bis [(E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S) -3,5-dihydroxyheptin 6-enoic acid] calcium salt
HK06110818A HK1090361A1 (en) 2003-09-10 2006-09-28 Crystalline form of bis (e)-7- 4-(4-fluorophenyl)-6-isopropyl-2- methyl(methylsulfonyl)amino pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6- enoicacid calcium salt
HR20090335T HRP20090335T1 (en) 2003-09-10 2009-06-10 CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT
CY20091100661T CY1109173T1 (en) 2003-09-10 2009-06-24 Crystalline form of bis [(E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [Methyl (methylsulfonyl) amino] pyrimidin-5-yl] -3,5-yl -6-LIGHT ACID] CALCIUM SALT
US12/615,935 US20100222373A1 (en) 2003-09-10 2009-11-10 Crystalline Form of Bis [(E)-7-[4-(4-fluoro-phenyl)-6-isopropyl-2-[methyl(methyl-sulfonyl)amino] pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt
US13/038,245 US8436167B2 (en) 2003-09-10 2011-03-01 Chemical compounds
US13/858,553 US20130225622A1 (en) 2003-09-10 2013-04-08 Crystalline Form of Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0321127A GB0321127D0 (en) 2003-09-10 2003-09-10 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0321127D0 true GB0321127D0 (en) 2003-10-08

Family

ID=29226781

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0321127A Ceased GB0321127D0 (en) 2003-09-10 2003-09-10 Chemical compounds

Country Status (2)

Country Link
GB (1) GB0321127D0 (en)
ZA (1) ZA200602009B (en)

Also Published As

Publication number Publication date
ZA200602009B (en) 2007-06-27

Similar Documents

Publication Publication Date Title
GB0317009D0 (en) Chemical compounds
GB0304194D0 (en) Chemical compounds
GB0308208D0 (en) Chemical compounds
GB0311276D0 (en) Chemical compounds
GB0319126D0 (en) Chemical compounds
GB0315203D0 (en) Chemical compounds
EP1648448A4 (en) Chemical compounds
GB0311274D0 (en) Chemical compounds
EP1590339A4 (en) Chemical compounds
GB0318422D0 (en) Chemical compounds
GB0318423D0 (en) Chemical compounds
EP1654251A4 (en) Chemical compounds
GB0308801D0 (en) Chemical compounds
GB0319690D0 (en) Chemical compounds
GB0306358D0 (en) Chemical compounds
GB0310724D0 (en) Chemical compounds
GB0314373D0 (en) Chemical compounds
GB0306357D0 (en) Chemical compounds
GB0304723D0 (en) Chemical compounds
GB0310464D0 (en) Chemical compounds
GB0315872D0 (en) Chemical compounds
GB0319149D0 (en) Chemical compounds
GB0314370D0 (en) Chemical compounds
GB0310828D0 (en) Chemical compounds
GB0314490D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)